HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
L Rubinstein Selected Research
L Rubinstein Research Topics
Disease
6
Neoplasms (Cancer)
01/2009 - 02/2000
2
Renal Cell Carcinoma (Grawitz Tumor)
01/2009 - 04/2004
1
Squamous Cell Carcinoma of Head and Neck
01/2009
1
Adenocarcinoma
01/2009
1
Breast Neoplasms (Breast Cancer)
01/2009
1
Hepatocellular Carcinoma (Hepatoma)
01/2009
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009
1
Colorectal Neoplasms (Colorectal Cancer)
01/2009
1
Disease Progression
01/2009
1
Ovarian Neoplasms (Ovarian Cancer)
01/2009
1
Stomach Neoplasms (Stomach Cancer)
01/2009
Drug/Important Bio-Agent (IBA)
2
Pharmaceutical Preparations
IBA
01/2009 - 04/2004
1
Cetuximab (Erbitux)
FDA Link
01/2009
1
Rituximab (Mabthera)
FDA Link
01/2009
1
Capecitabine (Xeloda)
FDA Link
01/2009
1
Irinotecan (Camptosar)
FDA Link
Generic
01/2009
1
Sorafenib (BAY 43-9006)
FDA Link
01/2009
1
Boron
IBA
01/2009
1
Cisplatin (Platino)
FDA Link
Generic
01/2009
1
Leucovorin (Folinic Acid)
FDA Link
01/2009
1
Fluorouracil (Carac)
FDA Link
Generic
01/2009
1
S-1 plus cisplatin
IBA
01/2009
1
taxane
IBA
01/2009
1
ixabepilone (BMS 247550)
FDA Link
01/2009
1
Bevacizumab (Avastin)
FDA Link
01/2009
1
Anthracyclines
IBA
01/2009
1
Platinum
IBA
01/2009
1
Cytochrome P-450 CYP1A1 (CYP1A1)
IBA
04/2004
1
aminoflavone
IBA
04/2004
1
Cytotoxins (Cytolysins)
IBA
02/2000
Therapy/Procedure
3
Therapeutics
01/2009 - 01/2009